Utility of FibroScan-based scoring systems to narrow the risk group of nonalcoholic fatty liver disease with comorbidities.

Kouichi Miura, Hiroshi Maeda, Naoki Morimoto, Shunji Watanabe, Mamiko Tsukui, Yoshinari Takaoka, Hiroaki Nomoto, Rie Goka, Kazuhiko Kotani, Hironori Yamamoto
{"title":"Utility of FibroScan-based scoring systems to narrow the risk group of nonalcoholic fatty liver disease with comorbidities.","authors":"Kouichi Miura,&nbsp;Hiroshi Maeda,&nbsp;Naoki Morimoto,&nbsp;Shunji Watanabe,&nbsp;Mamiko Tsukui,&nbsp;Yoshinari Takaoka,&nbsp;Hiroaki Nomoto,&nbsp;Rie Goka,&nbsp;Kazuhiko Kotani,&nbsp;Hironori Yamamoto","doi":"10.4291/wjgp.v13.i3.96","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Vibration-controlled transient elastography (VCTE) is proposed as a second step of examination to assess liver fibrosis in patients with nonalcoholic fatty liver disease (NAFLD) after triaging by the fibrosis-4 (FIB-4) index. Recently, VCTE-based scoring systems, including FibroScan-AST (FAST), Agile 3+, and Agile 4, emerged to determine the status of NAFLD. However, the significance of these scoring systems remains unknown in narrowing the high-risk group of NAFLD patients with comorbidities, including hepatocellular carcinoma (HCC) and esophagogastric varices (EGV).</p><p><strong>Aim: </strong>To clarify the significance of VCTE-based scoring systems to narrow the high-risk group of NAFLD patients with comorbidities.</p><p><strong>Methods: </strong>We performed a cross-sectional study to investigate the usefulness of VCTE-based scoring systems and other fibrosis markers to narrow the high-risk group of patients with NAFLD. FIB-4 index was used for the first triage. Risk groups of FAST, Agile 3+, and Agile 4 were stratified according to the published data. Among the 191 patients with NAFLD, there were 26 (14%) and 25 patients (13%) with HCC and EGV, respectively.</p><p><strong>Results: </strong>When 1.3 was used as a cutoff value, the FIB-4 index narrowed the risk group to 120 patients, in which all patients with HCC and/or EGV were included. High risk group of Agile 3+ could subsequently narrow the risk group. The prevalence of HCC and EGV at this step were 33% (26/80) and 31% (25/80), respectively. In further narrowing of EGV, Agile 4 aggregated the patients with EGV into 43 patients, of whom 23 (53%) had EGV. FAST failed to narrow the risk group of patients with comorbidities. When 2.6 was used as a cutoff value of the FIB-4 index, three patients with HCC and two patients with EGV were missed at the first triage.</p><p><strong>Conclusion: </strong>Agile 3+ and Agile 4 are useful to narrow the NAFLD patient group, in which patients may have HCC and/or EGV.</p>","PeriodicalId":23760,"journal":{"name":"World Journal of Gastrointestinal Pathophysiology","volume":"13 3","pages":"96-106"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/af/b3/WJGP-13-96.PMC9157683.pdf","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Gastrointestinal Pathophysiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4291/wjgp.v13.i3.96","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

Abstract

Background: Vibration-controlled transient elastography (VCTE) is proposed as a second step of examination to assess liver fibrosis in patients with nonalcoholic fatty liver disease (NAFLD) after triaging by the fibrosis-4 (FIB-4) index. Recently, VCTE-based scoring systems, including FibroScan-AST (FAST), Agile 3+, and Agile 4, emerged to determine the status of NAFLD. However, the significance of these scoring systems remains unknown in narrowing the high-risk group of NAFLD patients with comorbidities, including hepatocellular carcinoma (HCC) and esophagogastric varices (EGV).

Aim: To clarify the significance of VCTE-based scoring systems to narrow the high-risk group of NAFLD patients with comorbidities.

Methods: We performed a cross-sectional study to investigate the usefulness of VCTE-based scoring systems and other fibrosis markers to narrow the high-risk group of patients with NAFLD. FIB-4 index was used for the first triage. Risk groups of FAST, Agile 3+, and Agile 4 were stratified according to the published data. Among the 191 patients with NAFLD, there were 26 (14%) and 25 patients (13%) with HCC and EGV, respectively.

Results: When 1.3 was used as a cutoff value, the FIB-4 index narrowed the risk group to 120 patients, in which all patients with HCC and/or EGV were included. High risk group of Agile 3+ could subsequently narrow the risk group. The prevalence of HCC and EGV at this step were 33% (26/80) and 31% (25/80), respectively. In further narrowing of EGV, Agile 4 aggregated the patients with EGV into 43 patients, of whom 23 (53%) had EGV. FAST failed to narrow the risk group of patients with comorbidities. When 2.6 was used as a cutoff value of the FIB-4 index, three patients with HCC and two patients with EGV were missed at the first triage.

Conclusion: Agile 3+ and Agile 4 are useful to narrow the NAFLD patient group, in which patients may have HCC and/or EGV.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
基于fibroscan的评分系统用于缩小非酒精性脂肪性肝病合并症的风险组
背景:振动控制瞬时弹性成像(VCTE)被提议作为评估非酒精性脂肪性肝病(NAFLD)患者在纤维化-4 (FIB-4)指数分类后肝纤维化的第二步检查。最近,基于vcte的评分系统,包括纤维扫描- ast (FAST)、Agile 3+和Agile 4,出现用于确定NAFLD的状态。然而,这些评分系统在缩小NAFLD合并症高危人群(包括肝细胞癌(HCC)和食管胃静脉曲张(EGV))中的意义尚不清楚。目的:阐明基于vcte评分系统对缩小NAFLD合并症高危人群的意义。方法:我们进行了一项横断面研究,以调查基于vcte的评分系统和其他纤维化标志物对缩小NAFLD患者高危组的有用性。采用FIB-4指数进行首次分诊。根据已发表的数据对FAST、Agile 3+和Agile 4的风险组进行分层。191例NAFLD患者中,HCC和EGV患者分别为26例(14%)和25例(13%)。结果:当使用1.3作为临界值时,FIB-4指数将风险组缩小到120例,其中包括所有HCC和/或EGV患者。Agile 3+的高风险组随后会缩小风险组。此阶段HCC和EGV的患病率分别为33%(26/80)和31%(25/80)。为了进一步缩小EGV, Agile 4将EGV患者汇总为43例,其中23例(53%)为EGV。FAST未能缩小合并合并症患者的风险组。当FIB-4指数的临界值为2.6时,3例HCC患者和2例EGV患者在第一次分诊时被遗漏。结论:Agile 3+和Agile 4有助于缩小NAFLD患者组,其中可能有HCC和/或EGV。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Metabolic dysfunction-associated steatotic liver disease heterogeneity: Need of subtyping Sepsis during short bowel syndrome hospitalizations: Identifying trends, disparities, and clinical outcomes in the United States Des-gamma-carboxy prothrombin and alpha-fetoprotein levels as biomarkers for hepatocellular carcinoma and their correlation with radiological characteristics Changes in the terminology and diagnostic criteria of non-alcoholic fatty liver disease: Implications and opportunities Prevalence and outcome of sarcopenia in non-alcoholic fatty liver disease
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1